Delivery Order SPE2DB22D1052-SPE2DB24FU8FE
- Not listed
- This federal contract award, valued at $18,302.81, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Cyclosporine 0.05% eye emulsion, a specialized ophthalmic medication, to support military healthcare programs. The contract has an ultimate completion date of January 8, 2025 and is a Firm Fixed Price Delivery Order. This award is part of AmerisourceBergen's...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,354.96 firm fixed-price delivery order is for the supply of Cyclosporine 0.05% eye emulsion, a specialty pharmaceutical product. The contract has an ultimate completion date of December 18, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,333.59 firm fixed-price delivery order is for the supply of Cyclosporine 0.05% eye emulsion, a critical medication used in the treatment of various eye conditions. The contract has a period of performance through June 8, 2023 and does not have a set-aside designation, indicating open competition....
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,508.85 fixed-price delivery order is for the supply of Cyclosporine 0.05% eye emulsion, a prescription drug used to treat certain eye conditions. The contract has a period of performance through June 2024 and is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,152.79 firm fixed-price delivery order is for the supply of Cyclosporine 0.05% eye emulsion, a specialty pharmaceutical product. The contract has an ultimate completion date of November 22, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a significant customer of the prime contractor Amerisourcebergen Drug Corp. The $1,364.37 firm fixed price delivery order is for the supply of Cyclosporine 0.05% eye emulsion, a critical pharmaceutical product. Amerisourcebergen, a major pharmaceutical distributor, is leveraging its extensive supply chain to provide this medication to support military treatment programs and facilities. The...
- This federal contract award, valued at $8,756.59, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,561,312,299 units of cyclosporine 0.05% eye emulsion, a specialty medication. This is a firm-fixed-price delivery order with a completion date of June 22, 2023. The contract was not set aside for any specific business designation. AmerisourceBergen holds a significant Indefinite Delivery...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,639.83 firm fixed-price delivery order is for the supply of 4564793365 - Cyclosporine 0.05% Eye Emulsion 60s, with a completion date of June 4, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for...
- This federal contract award, valued at $9,374.25, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Cyclosporine 0.05% Eye Emulsion, a specialty medication, to support military healthcare programs. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract has an award value of $2,096.36 and is a Firm Fixed Price Delivery Order that runs through March 2025. The contract is for the supply of Cyclosporine 0.05% Eye Emulsion, a prescription eye medication. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at...
- SPE2DB22D1052Indefinite Delivery Contract
- SPE2DB22D1052-SPE2DB24FU8FEDelivery Order
This federal contract award, valued at $1,838.47, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is a delivery order for the supply of Cyclosporine 0.05% Eye Emulsion, a medication used to treat certain eye conditions. The contract has an ultimate completion date of January 2, 2024 and is a firm-fixed-price contract. In addition to this specific delivery order, AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs. The contract award did not have a set-aside designation, indicating open competition. AmerisourceBergen, a for-profit organization, is the prime contractor, and there is no mention of any major subcontractors in the provided information.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.8k | 12/29/23 |